AdvisorShares Investments’s Enveric Biosciences ENVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
103,679
+13,355
| +15% | +$16.2K | 0.02% | 237 |
|
|
2025
Q1 | $118K | Buy |
90,324
+50,334
| +126% | +$65.9K | 0.02% | 240 |
|
|
2024
Q4 | $215K | Buy |
39,990
+15,520
| +63% | +$83.4K | 0.04% | 221 |
|
|
2024
Q3 | $174K | Buy |
24,470
+3,334
| +16% | +$23.7K | 0.03% | 222 |
|
|
2024
Q2 | $190K | Buy |
21,136
+5,214
| +33% | +$46.8K | 0.03% | 225 |
|
|
2024
Q1 | $239K | Buy |
15,922
+6,466
| +68% | +$97K | 0.04% | 219 |
|
|
2023
Q4 | $184K | Sell |
9,456
-333
| -3% | -$6.49K | 0.04% | 231 |
|
|
2023
Q3 | $339K | Buy |
9,789
+3,094
| +46% | +$107K | 0.09% | 166 |
|
|
2023
Q2 | $338K | Sell |
6,695
-2,839
| -30% | -$144K | 0.1% | 162 |
|
|
2023
Q1 | $240K | Buy |
9,534
+1,781
| +23% | +$44.9K | 0.08% | 178 |
|
|
2022
Q4 | $238K | Buy |
7,753
+2,529
| +48% | +$77.8K | 0.07% | 207 |
|
|
2022
Q3 | $331K | Buy |
5,224
+3,554
| +213% | +$225K | 0.09% | 206 |
|
|
2022
Q2 | $268K | Buy |
1,670
+440
| +36% | +$70.6K | 0.07% | 126 |
|
|
2022
Q1 | $304K | Buy |
1,230
+829
| +207% | +$205K | 0.05% | 131 |
|
|
2021
Q4 | $279K | Buy |
401
+353
| +735% | +$246K | 0.03% | 134 |
|
|
2021
Q3 | $74K | Buy |
+48
| New | +$74K | 0.01% | 183 |
|